Essay Available:
Pages:
2 pages/≈550 words
Sources:
5
Style:
APA
Subject:
Health, Medicine, Nursing
Type:
Essay
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 9.72
Topic:
Case Report: Pfizer and the Challenges of the Pharmaceutical Industry
Essay Instructions:
Case Report: Pfizer and the Challenges of the Pharmaceutical Industry
The Case Write-Up –
• Don't fall into the trap that a case only has a specific chapter theme or
problem.
• Many problems exist in this case. While we will focus on a particular theme when
we discuss the case, all themes must be identified to understand how they impact the theme
being discussed.
• The write-ups should be typed, with one-inch margins on all sides; 12 pt. Times New Roman; page
numbers; single-space typed; and two pages (maximum length).
• This is not to be a review of the case. In this write-up, you need to be extremely specific. It would be best not to repeat any of the case details.
• The format of this case analysis should have the following headings:
Problems/Issues; Possible Solutions; Recommend Solutions; and Expected Outcomes.
• These write-ups are designed to be executive decision documents written so that your immediate report-to can read, understand, and implement your decision.
Essay Sample Content Preview:
Pfizer and the Challenges of the Pharmaceutical Industry
Student Name
Institutional Affiliation
Date
Pfizer and the Challenges of the Pharmaceutical Industry
Problems/Issues
Pharmaceutical companies like Pfizer face pricing challenges across different countries. In European countries, governments have been involved actively in the regulation of prices, which adversely affects the pricing of drugs. This makes it problematic for Pfizer to set up higher prices and improve its margins. In the US, the government has been less involved in regulating the prices of drugs, until recently (Kratochvil & Nell, 2020). This has exposed pharmaceutical companies to public and political pressure to reduce prices, which has further reduced profit margins. Secondly, established pharmaceutical companies like Pfizer are facing stiff competition from generics. Pharmacists in some countries are allowed to substitute prescribed drugs with unbranded generics having the same active ingredients (Kratochvil & Nell, 2020). At the same time, large pharmaceutical companies face a huge decline in sales when patent protection ends for their “breakthrough” or “first-in-class” drugs. The end of patent protection allows other firms to start selling generic copies of the same chemical, usually at much lower prices.
Possible Solutions
Pharmaceutical companies can address these challenges using the following ways. Firstly, they need to be actively engaged in negotiations with government health agencies and other organizations like insurance companies to negotiate drug prices. Pfizer can form partnerships with different stakeholders to understand the market needs and align its product offering to the goals of public health. Partnerships with ...
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now: